Bank of Montreal’s Takeda Pharmaceutical TAK Stock Holding History

Bank of Montreal’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.27M	Buy	204,241 +33,884	+20%	+$561K	﹤0.01%	1527
2026 Q1	$3.16M	Buy	170,357 +44,715	+36%	+$785K	﹤0.01%	1493
2025 Q4	$1.96M	Buy	125,642 +15,962	+15%	+$228K	﹤0.01%	1663
2025 Q3	$1.61M	Buy	109,680 +14,573	+15%	+$216K	﹤0.01%	1748
2025 Q2	$1.47M	Buy	95,107 +6,215	+7%	+$91.8K	﹤0.01%	1713
2025 Q1	$1.32M	Buy	88,892 +2,116	+2%	+$29.6K	﹤0.01%	1689
2024 Q4	$1.15M	Buy	86,776 +7,124	+9%	+$97.9K	﹤0.01%	1807
2024 Q3	$1.16M	Buy	79,652 +32,150	+68%	+$456K	﹤0.01%	1960
2024 Q2	$619K	Sell	47,502 -13,004	-21%	-$172K	﹤0.01%	2287
2024 Q1	$840K	Buy	60,506 +3,042	+5%	+$44.2K	﹤0.01%	2103
2023 Q4	$820K	Sell	57,464 -70,941	-55%	-$1.01M	﹤0.01%	2173
2023 Q3	$2.1M	Sell	128,405 -56,068	-30%	-$868K	﹤0.01%	1676
2023 Q2	$2.97M	Sell	184,473 -204,447	-53%	-$3.35M	﹤0.01%	1601
2023 Q1	$6.41M	Buy	388,920 +329,299	+552%	+$5.25M	﹤0.01%	1127
2022 Q4	$931K	Sell	59,621 -777	-1%	-$10.9K	﹤0.01%	2225
2022 Q3	$785	Buy	60,398 +2,750	+5%	+$38.2K	﹤0.01%	2323
2022 Q2	$802	Buy	57,648 +2,868	+5%	+$40.9K	﹤0.01%	2442
2022 Q1	$791K	Buy	54,780 +12,497	+30%	+$183K	﹤0.01%	2514
2021 Q4	$580K	Sell	42,283 -66,213	-61%	-$929K	﹤0.01%	2287
2021 Q3	$1.78M	Sell	108,496 -114,407	-51%	-$1.92M	﹤0.01%	2137
2021 Q2	$3.75M	Buy	222,903 +200,910	+914%	+$3.42M	﹤0.01%	1742
2021 Q1	$375K	Sell	21,993 -1,145	-5%	-$20.6K	﹤0.01%	2814
2020 Q4	$424K	Buy	23,138 +1,058	+5%	+$18.6K	﹤0.01%	2800
2020 Q3	$386K	Buy	22,080 +2,597	+13%	+$47.3K	﹤0.01%	2443
2020 Q2	$337K	Sell	19,483 -8,162	-30%	-$147K	﹤0.01%	2468
2020 Q1	$407K	Sell	27,645 -72,531	-72%	-$1.31M	﹤0.01%	2077
2019 Q4	$1.98M	Buy	100,176 +7	+0%	+$134	﹤0.01%	1889
2019 Q3	$1.72M	Buy	100,169 +20,526	+26%	+$355K	﹤0.01%	1781
2019 Q2	$1.41M	Buy	79,643 +2,512	+3%	+$45.7K	﹤0.01%	1890
2019 Q1	$1.57M	Buy	+77,131	New	+$1.55M	﹤0.01%	1807

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Bank of Montreal's TAK Position: Q2 2026 in Review

Bank of Montreal increased its Takeda Pharmaceutical (TAK) stake by 20% in Q2 2026, buying an estimated $561K and bringing the position to 204,241 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

Bank of Montreal first reported a position in TAK in Q1 2019 and has held it in 30 quarters since. The position peaked at $6.41M in Q1 2023. 357 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Bank of Montreal held 204,241 shares of Takeda Pharmaceutical worth $3.27M as of Q2 2026.
Bank of Montreal bought 33,884 Takeda Pharmaceutical shares in Q2 2026, an estimated $561K.
Takeda Pharmaceutical made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1527 holding.
Bank of Montreal first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
Bank of Montreal's Takeda Pharmaceutical position peaked at $6.41M in Q1 2023.
357 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.